US$ 24.43
retatrutide triple receptor agonist 🎙️ NEW EPISODE: Retatrutide—The *Not licensed* Will this replace the current GLP-1 in the market., This triple agonist (GIP/GLP-1/glucagon) is showing unprecedented results in Retatrutide (LY3437943): Mechanism of Action
Description
TikTok and social media is abuzz with users praising Ozempic for their significant weight loss and are coughing up between R1200 to R2500 a jab for the scheduled drug used to treat type 2 diabetes.

Cortisol and serotonin balance to support weight management and emotional resilience
Learn best practices for dry, lyophilized, and reconstituted peptides.

Shop All THRIVE products

FDA approves Jardiance (empagliflozin) tablets to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease
